Biogen Pharma's Q1 FY25 Financial Report Shows Decline in Performance, Receives 'Sell' Rating

Aug 01 2024 09:01 PM IST
share
Share Via
Biogen Pharmachem Industries, a microcap trading company, has reported a flat financial performance for the quarter ending June 2024, with a decline in operating profit, profit before tax, and earnings per share. MarketsMojo has given a 'Sell' call for the company's stock, indicating a negative trend in the near term.

Biogen Pharmachem Industries, a microcap trading company, has recently announced its financial results for the quarter ending June 2024. The company’s stock has been given a ‘Sell’ call by MarketsMOJO.

According to the financial report, Biogen Pharma’s performance for the quarter has been flat, with a score of -3 compared to 4 in the previous quarter. This indicates a decline in the company’s financial performance in the last three months.


The company’s operating profit (PBDIT) for the quarter was at its lowest in the last five quarters, standing at Rs -0.16 crore. This shows a negative trend in the near term for the company’s operating profit.


Similarly, the profit before tax less other income (PBT) for the quarter was also at its lowest in the last five quarters, at Rs -0.16 crore. This indicates a negative trend in the near term for the company’s PBT.


The earnings per share (EPS) for the quarter was also at its lowest in the last five quarters, at Rs -0.00. This shows a decline in profitability for the company, resulting in lower earnings for shareholders.


Overall, Biogen Pharmachem Industries has reported a negative financial performance for the quarter ending June 2024. Investors should take note of the company’s declining profitability and the ‘Sell’ call given by MarketsMOJO before making any investment decisions.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Biogen Pharma falling/rising?
Dec 06 2025 01:16 AM IST
share
Share Via
Why is Biogen Pharma falling/rising?
Nov 19 2025 10:32 PM IST
share
Share Via